CN Stock MarketDetailed Quotes
300147 Xiangxue Pharmaceutical
- 12.35
- +0.34+2.83%
Market Closed Dec 20 15:00 CST
8.17BMarket Cap-17.72P/E (TTM)
12.52High11.86Low409.69KlotVolume11.90Open12.01Pre Close498.30MTurnover6.23%Turnover RatioLossP/E (Static)661.28MShares16.4952wk High4.78P/B8.12BFloat Cap3.0052wk Low14.41Limit Up657.46MShs Float41.78Historical High9.61Limit Down5.50%Amplitude3.00Historical Low--Dividend TTM12.16Avg Price193.03KlotAsk--Div YieldTTM100Lot Size203.08KlotBid
Xiangxue Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.26%1.53B | -8.72%1.1B | -3.37%568.86M | 5.13%2.3B | -1.00%1.73B | 0.87%1.2B | -4.07%588.72M | -26.38%2.19B | -21.95%1.75B | -22.44%1.19B |
| Operating revenue | -11.26%1.53B | -8.72%1.1B | -3.37%568.86M | 5.13%2.3B | -1.00%1.73B | 0.87%1.2B | -4.07%588.72M | -26.38%2.19B | -21.95%1.75B | -22.44%1.19B |
| Other operating revenue | ---- | 45.56%11.17M | ---- | --26.76M | ---- | -64.27%7.67M | ---- | ---- | ---- | 2.44%21.48M |
| Total operating cost | -4.07%1.73B | -2.90%1.19B | 0.61%591.59M | -4.78%2.45B | -11.82%1.81B | -12.83%1.22B | -17.59%588M | -18.68%2.58B | -7.34%2.05B | -5.78%1.4B |
| Operating cost | -4.28%1.06B | -2.59%734.14M | 2.84%365.05M | -8.13%1.51B | -16.15%1.1B | -18.89%753.62M | -25.33%354.95M | -24.97%1.64B | -18.71%1.32B | -14.36%929.13M |
| Operating tax surcharges | -1.23%19.35M | -18.69%10.66M | -5.47%5.44M | 24.96%28.7M | 22.28%19.59M | 38.77%13.11M | 41.33%5.76M | -7.19%22.97M | 1.10%16.02M | -17.87%9.45M |
| Operating expense | -14.21%209.88M | -4.62%157.27M | -3.11%81.98M | 0.97%336.37M | -6.72%244.65M | -6.99%164.9M | -6.76%84.61M | -12.70%333.14M | 18.55%262.28M | 5.10%177.29M |
| Administration expense | 1.98%212.14M | 1.78%137M | 1.56%67.99M | -8.33%246.66M | -6.54%208.03M | -7.73%134.6M | 1.27%66.95M | -3.11%269.08M | 9.81%222.59M | 5.10%145.89M |
| Financial expense | -1.93%180.76M | -11.55%111.76M | -6.91%53.79M | 13.63%241.47M | 10.84%184.31M | 27.95%126.35M | -8.56%57.79M | 4.81%212.51M | 65.22%166.29M | 62.09%98.75M |
| -Interest expense (Financial expense) | -0.45%177.87M | -10.73%109.93M | -7.24%51.72M | 16.98%237.06M | 7.58%178.67M | 24.07%123.14M | -10.35%55.75M | 1.41%202.65M | 69.21%166.08M | 63.14%99.25M |
| -Interest Income (Financial expense) | -94.46%-1.74M | -74.30%-1.52M | 83.46%-184.78K | 27.94%-1.2M | 19.89%-895.06K | 22.09%-870.41K | -55.59%-1.12M | 79.75%-1.67M | 36.16%-1.12M | 59.30%-1.12M |
| Research and development | 18.44%53.06M | 21.71%35.35M | -3.42%17.33M | -5.31%89.76M | -29.46%44.8M | -29.02%29.05M | 27.48%17.94M | 4.62%94.79M | 28.72%63.51M | 81.28%40.92M |
| Credit Impairment Loss | 48.83%-2.26M | 141.63%749.77K | 56.13%-568.03K | 21.38%-17.11M | 75.85%-4.42M | -210.13%-1.8M | -142.17%-1.29M | -282.88%-21.76M | -448.38%-18.31M | -76.18%1.64M |
| Asset Impairment Loss | 96.83%-1.49M | 97.66%-1.02M | ---- | -17.87%-163.34M | -611.63%-47.11M | -671.11%-43.58M | ---- | 71.25%-138.58M | 225.87%9.21M | 779.82%7.63M |
| Other net revenue | 287.15%41.97M | 126.50%5.41M | -58.05%6.05M | -137.65%-179.53M | -132.67%-22.43M | -121.43%-20.43M | -75.34%14.43M | 80.04%-75.54M | 37.20%68.64M | 135.74%95.33M |
| Fair value change income | 91.02%-132.68K | 37.95%-57.56K | 136.85%29.46K | 23,074.82%2.73M | -114.81%-1.48M | -100.83%-92.75K | 98.93%-79.95K | -100.08%-11.88K | 143.55%9.97M | 94.57%11.23M |
| Invest income | 3,221.14%14.7M | -652.72%-5.05M | -28.15%498.07K | -206.99%-50.64M | -101.22%-471.14K | -98.28%913.36K | -98.72%693.18K | 40.91%47.33M | 787.90%38.59M | 2,217.49%53.21M |
| -Including: Investment income associates | 12.68%-425.1K | -134.35%-310.37K | -31.06%471.15K | -5,878.56%-52.16M | 90.42%-486.85K | 121.41%903.62K | 124.66%683.44K | 104.62%902.62K | 38.63%-5.08M | 6.26%-4.22M |
| Asset deal income | -21,433.38%-29.51M | -31,164.57%-42.35M | -882.10%-1.07M | -98.15%90.43K | -96.54%138.32K | -96.51%136.32K | 219.12%136.32K | 108.33%4.88M | 82,383.18%4M | --3.91M |
| Other revenue | 96.25%60.66M | 121.40%53.13M | -52.19%7.16M | 49.53%48.74M | 22.73%30.91M | 35.44%24M | 71.54%14.98M | -18.89%32.6M | -42.05%25.19M | -43.64%17.72M |
| Operating profit | -57.02%-156.29M | -106.93%-84.23M | -210.03%-16.68M | 28.32%-332.72M | 57.29%-99.53M | 64.64%-40.71M | 136.70%15.16M | 19.32%-464.14M | -402.48%-233.03M | -230.08%-115.11M |
| Add:Non operating Income | 46.31%1.12M | -3.05%575.14K | 7.33%196.37K | -10.55%1.08M | 29.99%762.69K | -17.34%593.21K | -58.27%182.96K | -40.16%1.21M | -80.50%586.71K | -66.94%717.64K |
| Less:Non operating expense | 14.19%32.67M | 76.61%32.05M | 44.26%9.85M | 17.14%57.32M | -25.12%28.61M | -45.01%18.15M | 305.87%6.83M | -0.32%48.93M | 126.02%38.2M | 256.01%33M |
| Total profit | -47.47%-187.84M | -98.60%-115.71M | -409.33%-26.33M | 24.01%-388.95M | 52.94%-127.38M | 60.47%-58.26M | 120.01%8.51M | 17.75%-511.86M | -528.59%-270.65M | -281.09%-147.39M |
| Less:Income tax cost | 100.44%9.05M | 3,867.33%5.17M | 893.70%2.3M | 288.30%12.8M | 37.95%4.52M | -97.82%130.37K | 135.99%231.14K | -127.78%-6.8M | -78.76%3.27M | -30.15%5.98M |
| Net profit | -49.28%-196.89M | -107.02%-120.88M | -445.69%-28.63M | 20.46%-401.75M | 51.85%-131.89M | 61.93%-58.39M | 119.77%8.28M | 21.91%-505.07M | -673.85%-273.92M | -310.61%-153.37M |
| Net profit from continuing operation | -49.28%-196.89M | -107.02%-120.88M | -445.69%-28.63M | 20.46%-401.75M | 51.85%-131.89M | 61.93%-58.39M | 119.77%8.28M | 21.91%-505.07M | -673.85%-273.92M | -310.61%-153.37M |
| Less:Minority Profit | 47.43%20.91M | 88.64%14.34M | 87.73%7.03M | -150.65%-12.78M | -42.67%14.18M | -55.50%7.6M | -69.99%3.74M | -15.23%25.24M | -19.80%24.73M | -24.11%17.09M |
| Net profit of parent company owners | -49.10%-217.8M | -104.90%-135.22M | -886.00%-35.66M | 26.65%-388.96M | 51.09%-146.07M | 61.28%-65.99M | 108.34%4.54M | 21.62%-530.31M | -1,867.80%-298.66M | -438.83%-170.46M |
| Earning per share | ||||||||||
| Basic earning per share | -50.00%-0.33 | -100.00%-0.2 | -600.00%-0.05 | 26.25%-0.59 | 51.11%-0.22 | 61.54%-0.1 | 112.50%0.01 | 21.57%-0.8 | -1,600.00%-0.45 | -425.00%-0.26 |
| Diluted earning per share | -50.00%-0.33 | -100.00%-0.2 | -600.00%-0.05 | 26.25%-0.59 | 51.11%-0.22 | 61.54%-0.1 | 112.50%0.01 | 21.57%-0.8 | -1,600.00%-0.45 | -425.00%-0.26 |
| Other composite income | 97.64%-65.25K | 103.68%99.45K | 100.09%3.93K | 185.42%6.89M | -263.01%-2.77M | -512.27%-2.71M | -2,738.43%-4.38M | -8,312.36%-8.06M | 82.02%1.7M | 384.33%656.14K |
| Other composite income of parent company owners | 97.64%-65.25K | 103.68%99.45K | 100.09%3.93K | 194.84%6.89M | -263.01%-2.77M | -512.27%-2.71M | -2,738.43%-4.38M | -7,477.49%-7.26M | 82.02%1.7M | 384.33%656.14K |
| Other composite income of minority owners | ---- | ---- | ---- | 100.00%0.08 | ---- | ---- | ---- | ---800K | ---- | ---- |
| Total composite income | -46.26%-196.95M | -97.69%-120.78M | -834.16%-28.63M | 23.05%-394.86M | 50.53%-134.66M | 59.99%-61.1M | 109.27%3.9M | 20.68%-513.13M | -659.35%-272.22M | -310.38%-152.72M |
| Total composite income of parent company owners | -46.37%-217.86M | -96.69%-135.12M | -23,224.86%-35.66M | 28.92%-382.08M | 49.88%-148.84M | 59.54%-68.7M | 100.28%154.19K | 20.56%-537.57M | -1,765.68%-296.96M | -439.09%-169.8M |
| Total composite income of minority owners | 47.43%20.91M | 88.64%14.34M | 87.73%7.03M | -152.31%-12.78M | -42.67%14.18M | -55.50%7.6M | -69.99%3.74M | -17.92%24.44M | -19.80%24.73M | -24.11%17.09M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Reservations with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Beijing Dahua International Accounting Firm (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
